Safety and efficacy of regorafenib in patients with treatment-refractory metastatic colorectal cancer in Turkey: the single-arm, open-label REGARD study.

Dane, Faysal

Safety and efficacy of regorafenib in patients with treatment-refractory metastatic colorectal cancer in Turkey: the single-arm, open-label REGARD study. [electronic resource] - BMJ open 03 2020 - e027665 p. digital

Publication Type: Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't

2044-6055

10.1136/bmjopen-2018-027665 doi


Administration, Oral
Adult
Aged
Antineoplastic Agents--therapeutic use
Colorectal Neoplasms--drug therapy
Disease Progression
Disease-Free Survival
Drug Administration Schedule
Female
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Phenylurea Compounds--therapeutic use
Pyridines--therapeutic use
Treatment Outcome
Turkey